Catalyst Wire Dossier Catalyst Wire Dossier

Enyglid

repaglinide · Krka, d.d., Novo mesto
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Enyglid, covering 2025-02-05 to 2025-02-05. Get the full timeline:

Most recent: EMA Authorised: Enyglid (repaglinide) — Krka, d.d., Novo mesto

See pricing